HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peptide vaccine trials for melanoma: preclinical background and clinical results.

AuthorsTony Talebi, Jeffrey S Weber
JournalSeminars in cancer biology (Semin Cancer Biol) Vol. 13 Issue 6 Pg. 431-8 (Dec 2003) ISSN: 1044-579X [Print] England
PMID15001162 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, Neoplasm
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • Melanoma-Specific Antigens
  • Neoplasm Proteins
  • Vaccines, Subunit
Topics
  • Antigens, Neoplasm
  • Histocompatibility Antigens Class I (immunology)
  • Histocompatibility Antigens Class II (immunology)
  • Humans
  • Melanoma (immunology, therapy)
  • Melanoma-Specific Antigens
  • Neoplasm Proteins (immunology)
  • Skin Neoplasms (immunology)
  • T-Lymphocytes (immunology)
  • Vaccines, Subunit (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: